How should subclinical hypothyroidism be managed, including indications for initiating levothyroxine therapy, appropriate initial dose, and follow‑up monitoring?

Management of Subclinical Hypothyroidism

For TSH 4.5-10 mIU/L, do not routinely treat with levothyroxine; instead, monitor TSH every 6-12 months, but for TSH >10 mIU/L, initiate levothyroxine therapy at 25-75 mcg daily based on TSH elevation. 1, 2

TSH-Based Treatment Algorithm

TSH 4.5-10 mIU/L (Mild Subclinical Hypothyroidism)

Routine treatment is NOT recommended 1. The evidence does not demonstrate clear benefits for early therapy compared to watchful waiting, and no studies show decreased morbidity or mortality with treatment 1.

• Monitoring approach: Repeat thyroid function tests at 6-12 month intervals 1
• Confirm diagnosis: Repeat TSH measurement 2-3 months after initial finding, as 62% of elevated TSH levels spontaneously normalize 3

Consider a trial of levothyroxine ONLY if:

• Patient has clear hypothyroid symptoms (fatigue, cold intolerance, weight gain)
• Trial duration: Several months
• Critical caveat: Continue therapy only if there is clear, objective symptomatic benefit 1
• The likelihood of improvement is small and must be balanced against inconvenience, expense, and potential risks (14-21% develop subclinical hyperthyroidism) 1

TSH >10 mIU/L (Severe Subclinical Hypothyroidism)

Levothyroxine therapy is reasonable and should be initiated 1. The 5% annual progression rate to overt hypothyroidism and potential prevention of cardiovascular and metabolic consequences justify treatment 1.

Initial dosing: 25-75 mcg daily, depending on degree of TSH elevation 2. This is lower than overt hypothyroidism treatment doses.

Special Populations Requiring Different Management

Pregnancy and Women Planning Pregnancy

All pregnant women or those planning pregnancy with elevated TSH should be treated immediately 1. This recommendation prioritizes fetal neurodevelopment over the lack of intervention trial data, given the association between elevated TSH and fetal wastage or neuropsychological complications 1.

Pregnancy-specific management:

• Goal TSH: <2.5 mIU/L in first trimester, <3.0 mIU/L in second trimester, <3.5 mIU/L in third trimester 2
• Monitoring frequency: Every 4 weeks during first half of pregnancy, then at least once between 26-32 weeks 2
• Dosing adjustment: Women already on levothyroxine typically need 30% dose increase (take one extra dose twice weekly) 4, 5
• Postpartum: Return to pre-pregnancy dose immediately after delivery 4

Elderly Patients (Age ≥70 Years)

Levothyroxine treatment is generally NOT recommended regardless of TSH level 6. Treatment may be harmful in elderly patients with subclinical hypothyroidism 3. The upper limit of normal TSH increases with age (7.5 mIU/L for patients >80 years) 3.

Patients with Cardiovascular Disease

For severe SCH (TSH >10 mIU/L) with underlying coronary artery disease or heart failure, levothyroxine treatment is necessary 6.

Initiation in cardiac patients:

• Start at lower dose: 12.5-50 mcg daily in patients >50-60 years or with known/suspected ischemic heart disease 2, 5
• Titrate slowly based on age and cardiac comorbidities 1

Follow-Up Monitoring

After initiating or adjusting levothyroxine:

• Recheck TSH in 6-8 weeks 4
• Once stable: Monitor every 6-12 months 4
• Target TSH: Within normal reference range (generally 0.5-2.0 mIU/L for non-pregnant adults) 7

Common Pitfalls to Avoid

1. Overtreating mild SCH: No evidence supports treating TSH 4.5-10 mIU/L for symptom improvement, cognitive function, or quality of life 3, 5, 8

2. Not confirming the diagnosis: Always repeat TSH measurement before initiating treatment, as many cases resolve spontaneously 3

3. Overtreatment causing iatrogenic hyperthyroidism: 14-21% of treated patients develop subclinical hyperthyroidism, increasing risks of atrial fibrillation and osteoporosis 1, 7

4. Treating elderly patients unnecessarily: Treatment may cause harm in patients >70 years 6, 3

5. Missing pregnancy: Always assess pregnancy status in women of childbearing age, as management differs dramatically 1

Administration Details

• Timing: Take levothyroxine with water 30-60 minutes before breakfast or at bedtime 4 hours after last meal 2
• Avoid interference: Do not take with substances that interfere with absorption (calcium, iron, soy, fiber) 2, 4